Log in to save to my catalogue

Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?

Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8860795

Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?

About this item

Full title

Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?

Publisher

Cham: Springer International Publishing

Journal title

Neurological sciences, 2022-03, Vol.43 (3), p.1993-2001

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Objective
Epilepsy treatment during pregnancy is still challenging. The study is aimed at comparing the efficacy and safety of carbamazepine (CBZ), lamotrigine (LTG) and levetiracetam (LEV) monotherapies during pregnancy in women with focal (FE) or generalized (GE) epilepsy.
Methods
A multicentre retrospective study was conducted to evalua...

Alternative Titles

Full title

Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8860795

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8860795

Other Identifiers

ISSN

1590-1874

E-ISSN

1590-3478

DOI

10.1007/s10072-021-05542-2

How to access this item